Macular Masquerades
Date: 7/09/2022 (AEST)
Venue: The Maribyrnong Boathouse, 7 The Boulevard, Moonee Ponds, VIC, 3039
Provider: Novartis
Contact: Charlie Almond, [E] Charlie.almond@novartis.com, [P] 0481450278
Learning Objectives
- Confidently identify AMD, DMO, and CMO secondary to RVO on OCT
- Develop a differential for macular pathology as seen on OCT
- Identify signs on OCT which may suggest another cause of macular pathology other than AMD and DMO
- Understand causes and treatments of patients developing Diplopia post cataract surgery
- Develop a better understanding of assessment of the post-surgical socket in relation to enucleation with implant versus evisceration
- Develop a better understanding of assessment of the causes of discomfort and discharge and how these issues are treated
- Develop a better understanding of the psychological issues that patients have with their seeing eye and concerns about the cosmoses of the prosthesis
Max CPD hours awarded: 2.75
Session Information
| Name |
|---|
| Macular Masquarades |
| Clinical? |
| Yes |
| Interactive? |
| Yes |
| Therapeutic? |
| No |
| Duration of CPD Session/Module |
| 1 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 1.25 |
| Name |
|---|
| Diplopia Post-Cataract Surgery |
| Clinical? |
| Yes |
| Interactive? |
| Yes |
| Therapeutic? |
| No |
| Duration of CPD Session/Module |
| 0.75 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 1 |
| Name |
|---|
| Artificial Eyes |
| Clinical? |
| Yes |
| Interactive? |
| Yes |
| Therapeutic? |
| No |
| Duration of CPD Session/Module |
| 0.25 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.5 |